Company / Cash & Equivalents
Addus HomeCare Corp. Cash & Equivalents History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$98.9M
FY2024
5-year range
$64.8M / $168.9M
FY2020-FY2024
Trend
+52.7%
vs FY2023
Sector context
#113 of 152
Health Care
What the data says
At $99M, Addus HomeCare Corp.'s cash & equivalents ranks #113 of 152 in the Health Care sector. Cash & Equivalents returned to growth in FY2024 after 2 years of decline, reaching $99M.
Based on SEC 10-K filings.
$99M in FY2024 with a 5-year CAGR of -2.4%.
Improved from $80M to $99M over the past 2 years.
Health Care sector context is included.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- -16.3%
- 5-Year CAGR
- -2.4%
- 10-Year CAGR
- -
Sector benchmark
#113 of 152 in Health CareTop 74% of 152This company $98.9M Sector average $1.2B
▼
-91.5% below sector average
Key checks
Key Insights
- 5-year CAGR of -2.4%, indicating a declining trend.
- In FY2024, cash & equivalents increased 52.7% year-over-year.
- Ranks #113 out of 152 companies in the Health Care sector.
- Peak cash & equivalents was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 2.92 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $98.9M | +52.7% |
| FY2023 | $64.8M | -19.0% |
| FY2022 | $80.0M | -52.7% |
| FY2021 | $168.9M | +16.4% |
| FY2020 | $145.1M | +29.9% |
| FY2019 | $111.7M | +58.7% |
| FY2018 | $70.4M | +31.0% |
| FY2017 | $53.8M | +570.8% |
| FY2016 | $8.0M | +95.2% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026